We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

International Flavors & Fragrances (IFF) Common Stock USD0.125

Sell:$134.08 Buy:$134.24 Change: $2.47 (1.81%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $2.47 (1.81%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $2.47 (1.81%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

International Flavors & Fragrances Inc. offers sensory, food and beverage, pharmaceutical, health and wellness, home and personal care solutions and ingredients. It operates through segments such as Nourish, Scent, Health & Biosciences, and Pharma Solutions. The Nourish segment consists portfolio of natural-based ingredients to improve nutritional value, texture and functionality in a range of beverage, dairy, bakery, confectionery and culinary applications. The Scent segment consists of its legacy Scent segment as well as its Flavor Ingredients business. The Health & Biosciences segment includes a biotechnology-driven probiotics portfolio, that produces cultures for use in fermented foods such as yogurt, cheese and fermented beverages. The Pharma Solutions segment consists of cellulosics and alginates-based pharma excipients.

Contact details

521 W 57TH ST
United States
+1 (212) 7655500

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$35.89 billion
Shares in issue:
254.55 million
Specialty Chemicals
New York Stock Exchange
United States
US dollar

Key personnel

  • Andreas Fibig
    Chairman of the Board, Chief Executive Officer
  • Franklin Clyburn
    Chief Executive Officer, Director
  • Glenn Richter
    Chief Financial Officer, Executive Vice President
  • Christophe De Villeplee
    President, Scent
  • Simon Herriott
    President - Health and Biosciences
  • Nicolas Mirzayantz
    President, Nourish
  • Angela Strzelecki
    President, Pharma Solutions
  • Susana Suarez-Gonzalez
    Chief Human Resource Officer and Diversity & Inclusion Officer, Executive Vice President
  • Vic Verma
    Executive Vice President, Chief Information Officer
  • Jennifer Johnson
    Executive Vice President, General Counsel

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.